The SIRT1 Pathway: Genetics, NAD+, and Cellular Repair

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on longevity and telomeres. Browse all Longevity & Telomeres education

Among the longevity genes generating the most serious scientific attention, SIRT1 occupies a unique position: it is not a fixed structural element of your biology but a dynamic regulator — an enzyme whose activity rises and falls with metabolic signals, particularly NAD+ availability. The Precision Peptide Genetic Test analyzes SIRT1 as one of 17 Longevity & Aging insights, part of a broader panel spanning 14 pathways, 49 peptides, and 150+ genetic insights. Your SIRT1 genetic profile reveals your baseline capacity in this regulatory system — how efficiently your cells deploy sirtuin-mediated repair under normal conditions, and how much leverage NAD+ pathway support may provide in your specific biology.

What SIRT1 Does

SIRT1 (sirtuin 1) is a protein deacetylase — an enzyme that removes acetyl groups from target proteins, changing how those proteins function. Because acetylation and deacetylation regulate protein activity broadly, SIRT1's target list is long and consequential: it deacetylates histones to regulate gene expression, p53 to modulate DNA damage response, NF-κB to suppress inflammatory signaling, PGC-1α to activate mitochondrial biogenesis, and MnSOD (the enzyme encoded by SOD2) to enhance antioxidant enzyme activity. Every one of those targets is a major lever in cellular aging. The unifying constraint on all of this: SIRT1 requires NAD+ as a cofactor to function. Without adequate NAD+, SIRT1 cannot deacetylate any of its targets, regardless of what its genetic variant says about its baseline efficiency.

The NAD+–SIRT1 Relationship

NAD+ (nicotinamide adenine dinucleotide) is consumed as a substrate in each SIRT1 deacetylation reaction. NAD+ levels decline with age — a reduction attributed to decreased biosynthesis, increased NAD+-consuming enzyme activity (particularly PARP enzymes responding to accumulated DNA damage), and reduced mitochondrial efficiency. As NAD+ falls, SIRT1 activity falls with it, regardless of genotype. This is the mechanism behind the longevity research interest in NAD+ pathway support: restoring NAD+ levels restores the substrate that allows SIRT1 to function. Your SIRT1 genetic profile tells you about the baseline efficiency of the enzyme itself; NAD+ availability tells you whether that enzyme has the substrate it needs to operate.

SIRT1 Genetic Variants — What the Research Shows

Several SIRT1 SNPs have been studied for associations with metabolic and longevity-related phenotypes. The variant rs12778366, located in the SIRT1 promoter region, has been associated with differences in SIRT1 expression — affecting how much SIRT1 protein is produced under baseline conditions. Related variants at rs7895833 and rs2023938 have been studied in the context of metabolic syndrome, caloric restriction response, and lifespan in model organisms. Unlike FOXO3's centenarian replication record, SIRT1 variants show more moderate effect sizes in human longevity cohorts — consistent with SIRT1's role as a nutrient-sensing regulator whose activity is heavily influenced by environment, not just genotype. The signal from your SIRT1 result is therefore best interpreted alongside your NAD+ pathway behaviors and the rest of your longevity panel, not in isolation.

SIRT1's Relationship to the Other Longevity Genes

SIRT1 operates within a network of longevity regulators that includes the other genes in the panel. FOXO3 — the centenarian gene — has its activity partially regulated by SIRT1-mediated deacetylation, extending FOXO3's nuclear presence and activating its stress-defense programs; for the FOXO3 deep dive, see the FOXO3 Longevity Gene post. SOD2 — the mitochondrial antioxidant enzyme — is directly deacetylated and activated by SIRT1, creating a functional bridge between the sirtuin pathway and MnSOD activity that is independent of SOD2 genotype; for the full SOD2 analysis, see the SOD2 Oxidative Stress post. APOE's interaction with lipid metabolism also intersects with SIRT1's PGC-1α target — through mitochondrial biogenesis. The Peptide Pathways Report synthesizes these cross-gene interactions across the full 17-insight longevity panel.

SIRT1 and Caloric Restriction Mimetics

The most studied environmental activator of SIRT1 is caloric restriction — reducing energy intake in a way that raises NAD+/NADH ratio and activates the sirtuin response. The research interest in longevity-associated compounds partly stems from their potential to activate SIRT1 signaling without requiring constant caloric restriction. Your SIRT1 genetic baseline informs how much inherent capacity exists in this regulatory system and how responsive your biology may be to interventions that modulate the NAD+ pathway — always a conversation for a qualified healthcare provider to evaluate in the context of your complete clinical picture. For the full longevity pathway context, see the Complete Guide to Genetic Longevity Testing.

Genetics as a Guide, Not a Guarantee

A less active SIRT1 baseline doesn't mean cellular repair is absent — it means this regulatory layer is less efficient at the genetic level and more dependent on adequate NAD+ supply, lifestyle inputs, and the rest of the antioxidant defense network. A more active SIRT1 baseline doesn't make aging optional. What your SIRT1 result provides is a clearer picture of where this specific lever sits in your longevity biology — useful context for every decision that follows. That precision is what testing before you invest in any longevity protocol is designed to deliver.

The Precision Peptide Genetic Test analyzes how your genes influence longevity and aging pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to see your longevity genetic profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions

What does the SIRT1 gene reveal about cellular repair?

SIRT1 reveals your baseline efficiency in sirtuin-mediated cellular repair — the NAD+-dependent system that regulates DNA damage response, mitochondrial biogenesis, antioxidant activation, and inflammatory signaling. Variants at rs12778366 influence baseline SIRT1 expression. Part of 17 Longevity & Aging insights in the Precision Peptide Genetic Test, spanning 14 pathways and 150+ insights.

What is the connection between SIRT1 and NAD+?

SIRT1 requires NAD+ as a cofactor to deacetylate its targets — without NAD+, SIRT1 cannot function regardless of genotype. NAD+ declines with age, suppressing SIRT1 activity in all genotypes. Your SIRT1 genetic profile reveals the enzyme's baseline efficiency; NAD+ availability determines whether that enzyme has the substrate it needs to operate at capacity.

How does my SIRT1 result connect to longevity protocols?

Your SIRT1 result reveals how efficiently your sirtuin repair system operates at genetic baseline — and how much leverage NAD+ pathway support may provide in your biology. Less active variants suggest this pathway is more substrate-dependent. Results inform the conversation with a qualified healthcare provider, who evaluates SIRT1 findings alongside your full 17-insight longevity panel.

This article is part of the PlexusDx Education Hub. Browse all Longevity & Telomeres education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.